new data findings/day
patient tests analyzed
Access over 40 genomic, clinical and pharmaceutical databases updated weekly by hundreds of expert curators.
Enrich your NGS analysis and interpretations with cutting-edge software solutions trusted by thousands worldwide.
Make improvements in life possible by partnering with one provider empowering you from Sample to Insight.
As part of our effort to provide enhanced user experiences for the Human Gene Mutation Database (HGM...
QIAGEN Discovery Bioinformatics Services offer custom solutions that help translate discovery from y...
"A person’s microbiome not only affects their overall health, but also the effectiveness of certai...
Researchers across the world are using QIAGEN Digital Insights solutions to accelerate their work in...
In order to provide the best software and product support for our customers, QIAGEN must periodicall...
New changes to how you login to HGMD Professional and download HGMD data, GenomeTrax, and ANNOVAR
Antibody Analysis Suite: A custom solution from QIAGEN Discovery Bioinformatics Services
Meet the speaker: Dr. Hannah Wardill, Ph.D. – QIAGEN CLC online User Group Meeting, May 26 and 27, 2020
QIAGEN Digital Insights Publication Roundup (Summer 2020)
End of Life Notice: Ingenuity Variant Analysis (IVA)
Targeted NGS panels and optimized analysis and interpretation tools.
Discovery Bioinformatics Services is a reliable and convenient way to extend your in-house resources with expertise and perfectly tailored bioinformatics services that ensure high-quality results.
Enabling pharma companies to develop biomarker diagnostics and targeted therapies using real-world insights from oncology patient genomic data.
Helping clinical testing laboratories leverage the benefits of automation and expert support to improve test turnaround times, enhance clinical reporting capabilities and scale for future growth.
Join us at an event or attend a webinar to learn how our products, solutions and services are empowering customers around the world to unlock valuable molecular insights.
Çukurova University in Adana, Turkey, analyzes the ancient origins of rare genetic diseases
Scientists at the University of Washington develop new Ebola model and find clues to genetics of host resistance
Mount Sinai identifies a novel prognostic biomarker associated with treatement response in ovarian cancer patients